GHP Q2 2023

GHP Q2 2023 Western Fjords Advanced Technologies received pre-seed investment to develop and complete preliminary in vitro studies. Currently, opportunities are available for investors for longterm partnering. As this ingenious award-winning company has recently been named as the Most Innovative Novel Therapeutics Developer 2023 – Nordics, for its incredible advances in biopharmaceutical technology, surely new opportunities are not far away. Company: Western Fjords Advanced Technologies LLC Web Address: Contact Name: Thor Hoegnason